Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin with PFMT and WBVT in Overactive Bladder
NCT01314781Phase 4Completed
- Sponsor
- Kantonsspital Frauenfeld
- Start
- Jan 2012
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder syndrome (OAB), sponsored by Kantonsspital Frauenfeld. Started Jan 2012; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT01314781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01314781.